Enrofloxacin-associated retinal degeneration in cats

Veterinary Ophthalmology

Volumn 4, Issue 2, 2001, Pages 99-106

  Gelatt, Kirk N ^a   Van Der Woerdt, Alexandra ^b   Ketring, Kerry L ^c   Andrew, Stacy E ^a   Brooks, Dennis E ^a   Biros, Daniel J ^a   Denis, Heidi M ^a   Cutler, Timothy J ^a  

^a University of Florida College of Veterinary Medicine   (United States)

^b ANIMAL MEDICAL CENTER   (United States)

^c All Animal Eye Clinic   (United States)

Author keywords

Enrofloxacin; Feline; Retinal degeneration

Indexed keywords

ANIMALIA; FELIDAE; FELIS CATUS;

ANTIINFECTIVE AGENT; ENROFLOXACIN; QUINOLONE DERIVATIVE;

ACUTE DISEASE; ANIMAL; ANIMAL DISEASE; ARTICLE; BLINDNESS; CAT; CAT DISEASE; CHEMICALLY INDUCED DISORDER; FEMALE; INFORMATION PROCESSING; MALE; PATHOLOGY; RETINA DEGENERATION; RETROSPECTIVE STUDY;

ACUTE DISEASE; ANIMALS; ANTI-INFECTIVE AGENTS; BLINDNESS; CAT DISEASES; CATS; FEMALE; FLUOROQUINOLONES; MALE; QUINOLONES; RECORDS; RETINAL DEGENERATION; RETROSPECTIVE STUDIES;

EID: 0035375256     PISSN: 14635216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-5224.2001.00182.x     Document Type: Article

References (33)

1. Rubin LF, Gelatt KN. Corneal epithelial sloughing in dogs with glaucoma. Journal of the American Veterinary Medical Association 1967; 151: 1449-1452.
2. Koch SA, Rubin LF. Ocular sensitivity of dogs to topical tetracaine. Journal of the American Veterinary Medical Association 1969; 154: 15-16.
3. Hollingsworth SR, Canton DD, Buyukmihci NC. Effect of topically administered atropine on tear production in dogs. Journal of American Veterinary Medical Association 1992; 200: 1481-1484.
4. Gelatt KN, Peiffer RL, Erickson JL et al. Evaluation of tear formation in the dog, using a modification of the Schirmer tear test. Journal of the American Veterinary Medical Association 1975; 166: 368-370.
5. Gelatt KN, MacKay EO, Gelatt JK et al. Effects on intraocular pressure and pupil size in glaucomatous Beagles after topical pilocarpine instilled with standard (pH 5) and buffer-tip (pH 7) droptainers. Journal of Ocular Pharmacology and Therapeutics 1997; 13: 95-104.
6. Krohne SG, Gionfriddo J, Morrison EA. Inhibition of pilocarpine-induced aqueous humor flare, hypotony, and miosis by topical administration of anti-inflammatory and anesthetic drugs to dogs. American Journal of Veterinary Research 1998; 59: 482-488.
7. Gelatt KN, MacKay EO. The ocular hypertensive effects of topical 0.1% dexamethasone in Beagles with inherited glaucoma. Journal of Ocular Pharmacology and Therapeutics 1998; 14: 57-65.
8. Keates EU, Druzgala PD, Howes JF et al. Loteprednol etabonate: a new steroid without ocular hypertensive effect. Investigative Ophthalmology and Visual Science (Abstract) 1991; 32: 947.
9. Martin CL. Ocular manifestations of systemic disease. Part 1. The dog. In: Veterinary Ophthalmology, 3rd edn (ed. Gelatt KN) Lippincott/Williams & Willdns, Philadelphia, 1999; 1401-1448.
10. Diehl KJ, Roberts SM. Keratoconjunctivitis sicca in dogs associated with sulfonamide therapy: 16 cases (1980-1990). Progress in Veterinary and Comparative Ophthalmology 1991; 1: 276-282.
11. Gratzek AT, Calvert CA, Martin CL et al. Corneal edema in dogs treated with tocainide. Progress in Veterinary and Comparative Ophthalmology 1993; 3: 47-51.
12. Martin CL, Christmas R, Leipold HW. Formation of temporary cataracts in dogs given a disophenol preparation. Journal of the American Veterinary Medical Association 1972; 161: 294-301.
13. Vogel AW, Kaiser JA. Ethambutol induced transient change and reconstitution (in vivo) of the tapetal lucidum in the dog. Experimental Pathology (Suppl. 2) 1963; 136-149.
14. Budinger JM. Diphenylthiocarbazone blindness in dogs. Archives of Pathology 1961; 71: 304-310.
15. Delahunt CS, Stebbins RB, Anderson J et al. The cause of blindness of dogs given hydroxypyridinethione. Toxicology and Applied Pharmacology 1971; 4: 286-291.
16. Fortner JH, Milisen WB, Lundeen GR et al. Tapetal effect of an azalide antibiotic following oral administration in Beagle dogs. Fundamental and Applied Toxicology 1993; 21: 164-173.
17. Entee KM, Grauwels M, Clercx C et al. Closantel intoxication in a dog. Veterinary and Human Toxicology 1995; 37: 234-236.
18. Ketring KL. Presumed ocular toxicity of ivermectin. Proceedings of the 13th Annual Kal Kan Symposium, 109-110. The Ohio State University, 1989.
19. Zhan G-L, Mirandi OC, Bito LZ. Steroid glaucoma: corticosteroid-induced ocular hypertension in cats. Experimental Eye Research 1992; 54: 211-218.
20. Bhattacherjee P, Paterson CA, Spellman JM et al. Pharmacological validation of a feline model of steroid-induced ocular hypertension. Archives of Ophthalmology 1999; 117: 361-364.
21. Davidson MG, Baty KT. Anaphylaxis associated with intravenous sodium fluorescein administration in a cat. Progress in Veterinary and Comparative Ophthalmology 1991; 1: 127-128.
22. Willis M, Martin CL, Stiles J et al. Acute transient sialoadenomegaly in two cats following topical administration of tropicamide. Veterinary and Comparative Ophthalmology 1997; 7: 206-208.
23. Schaller JP, Wyman M, Weisbrode SE et al. Induction of retinal degeneration in cats by methylnitrosourea and ketamine hydrochloride. Veterinary Pathology 1981; 18: 239-247.
24. Giuliano EA, van der Woerdt A. Feline retinal degeneration: clinical experience and new findings (1994-1997). Journal of the American Animal Hospital Association 1998; 35: 511-514.
25. Glaze MB, Gelatt KN. Feline ophthalmology. In: Veterinary Ophthalmology, 3th edn (ed. Gelatt KN) Lippincott/Williams & Wilkins, Philadelphia, 1999; 997-1052.
26. Meier-Ruge W. Experimental investigation of the morphogenesis of chloroquine retinopathy. Archives of Ophthalmology 1965; 73: 540-543.
27. Wilton LV, Pearce GL, Mann RD. A comparison of ciprofloxacin, norfloracin, ofloxacin, azithromycin, and cefixime examined by observational cohort studies. British Journal of Clinical Pharmacology 1996; 41: 277-284.
28. De Sarro A, Cecchetti V, Fravolini V et al. Effects of novel 6-desfluoroquinolones and classic quinolones on pentylenetrazole-induced seizures in mice. Antimicrobial Agents and Chemotherapy 1999; 43: 1729-1736.
29. Delon A, Bouquet S, Huguet F et al. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats. Antimicrobial Agents and Chemotherapy 1999; 43: 1511-1555.
30. Cohen RG, Raizman M, Callina C, Lahav M. Retinal safety of oral and topical ofloxacin in rabbits. Journal of Ocular Pharmacology and Therapeutics 1997; 13: 369-379.
31. Wiechens B, Neumann D, Grammar JB et al. Retinal toxicity of liposome-incorporated and free ofloxacin after intravitreal injection in rabbit eyes. International Ophthalmology 1998; 22: 133-143.
32. Wiechens B, Grammar JB, Johannsen U et al. Experimental intravitreal application of ciprofloxacin in rabbits. Ophthalmologica 1999; 213: 120-128.
33. 3. Boeckh A. Antibacterial agents. In: The Merck Veterinary Manual, 8th edn (ed. Aiello SA) Merck, Whitehouse Station, 1998; 1761-1765.